Managing Recurrence after Radical Prostatectomy
Adam S. Kibel, MD, explores managing prostate cancer recurrence following radical prostatectomy.
Read MoreSelect Page
Posted by Adam S. Kibel, MD | Apr 2025
Adam S. Kibel, MD, explores managing prostate cancer recurrence following radical prostatectomy.
Read MorePosted by Quoc-Dien Trinh, MD, MBA | Mar 2025
Quoc-Dien Trinh, MD, MBA, discusses community outreach and efforts to address racial disparities in prostate cancer outcomes.
Read MorePosted by Adam S. Kibel, MD | Feb 2025
Adam S. Kibel, MD, delves into strategies for prostate cancer detection, emphasizing the role of MRI and biomarkers in diagnostic accuracy.
Read MorePosted by Adam S. Kibel, MD | Feb 2025
Adam S. Kibel, MD, presents on high-risk prostate cancer management.
Read MorePosted by Peter F. Orio III, DO, MS | Oct 2023
Peter F. Orio III, DO, MS, discusses the critical role of rectal spacing in reducing the toxicity associated with radiation therapies in the treatment of prostate cancer. While not yet FDA approved, Dr. Orio reviews several pivotal trials on SpaceOAR and Barrigel which support the use of rectal spacing technology in prostate cancer treatment.
Dr. Orio underscores the role of rectal spacing technology in a patient-centric approach to cancer care. Throughout his presentation, Dr. Orio focuses on the mechanisms behind rectal spacing technology which preserve patient quality of life more effectively than traditional approaches when done correctly.
Dr. Orio then reviews the weaknesses and dangers of rectal spacer technology and analyzes reports in the FDA MAUDE database for SpaceOAR Classic, SpaceOAR Vue, and Barrigel. He cautions physicians and surgeons to know their own skill-level and to always choose the safety of the patient.
Read More